These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 21328449)
21. Adenovirus-mediated transfer of wild-type p53 gene sensitizes TNF resistant MCF7 derivatives to the cytotoxic effect of this cytokine: relationship with c-myc and Rb. Ameyar M; Shatrov V; Bouquet C; Capoulade C; Cai Z; Stancou R; Badie C; Haddada H; Chouaib S Oncogene; 1999 Sep; 18(39):5464-72. PubMed ID: 10498900 [TBL] [Abstract][Full Text] [Related]
22. Expression of p57kip2, Rb protein and PCNA and their relationships with clinicopathology in human pancreatic cancer. Yue H; Na YL; Feng XL; Ma SR; Song FL; Yang B World J Gastroenterol; 2003 Feb; 9(2):377-80. PubMed ID: 12532471 [TBL] [Abstract][Full Text] [Related]
23. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status. Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024 [TBL] [Abstract][Full Text] [Related]
24. Gankyrin: an intriguing name for a novel regulator of p53 and RB. Lozano G; Zambetti GP Cancer Cell; 2005 Jul; 8(1):3-4. PubMed ID: 16023592 [TBL] [Abstract][Full Text] [Related]
25. L2DTL/CDT2 and PCNA interact with p53 and regulate p53 polyubiquitination and protein stability through MDM2 and CUL4A/DDB1 complexes. Banks D; Wu M; Higa LA; Gavrilova N; Quan J; Ye T; Kobayashi R; Sun H; Zhang H Cell Cycle; 2006 Aug; 5(15):1719-29. PubMed ID: 16861890 [TBL] [Abstract][Full Text] [Related]
26. Immunohistochemical evaluation of adenomatous polyposis coli, beta-catenin, c-Myc, cyclin D1, p53, and retinoblastoma protein expression in syndromic and sporadic fundic gland polyps. Hassan A; Yerian LM; Kuan SF; Xiao SY; Hart J; Wang HL Hum Pathol; 2004 Mar; 35(3):328-34. PubMed ID: 15017589 [TBL] [Abstract][Full Text] [Related]
27. Mechanism of secalonic acid D-induced inhibition of transcription factor binding to cyclic AMP response element in the developing murine palate. Hanumegowda UM; Dhulipala VC; Reddy CS Toxicol Sci; 2002 Nov; 70(1):55-62. PubMed ID: 12388835 [TBL] [Abstract][Full Text] [Related]
28. p53 post-translational modification: deregulated in tumorigenesis. Dai C; Gu W Trends Mol Med; 2010 Nov; 16(11):528-36. PubMed ID: 20932800 [TBL] [Abstract][Full Text] [Related]
29. p53-independent dephosphorylation and cleavage of retinoblastoma protein during tamoxifen-induced apoptosis in human breast carcinoma cells. Fattman CL; An B; Sussman L; Dou QP Cancer Lett; 1998 Aug; 130(1-2):103-13. PubMed ID: 9751262 [TBL] [Abstract][Full Text] [Related]
30. Adenovirus E1A oncoprotein liberates c-Myc activity to promote cell proliferation through abating Bin1 expression via an Rb/E2F1-dependent mechanism. Kinney EL; Tanida S; Rodrigue AA; Johnson JK; Tompkins VS; Sakamuro D J Cell Physiol; 2008 Sep; 216(3):621-31. PubMed ID: 18348166 [TBL] [Abstract][Full Text] [Related]
31. Posttranslational protein modifications: current implications for cancer detection, prevention, and therapeutics. Krueger KE; Srivastava S Mol Cell Proteomics; 2006 Oct; 5(10):1799-810. PubMed ID: 16844681 [No Abstract] [Full Text] [Related]
32. The RB and p53 pathways in cancer. Sherr CJ; McCormick F Cancer Cell; 2002 Aug; 2(2):103-12. PubMed ID: 12204530 [TBL] [Abstract][Full Text] [Related]
34. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Tan A; Etit D; Bayol U; Altinel D; Tan S Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633 [TBL] [Abstract][Full Text] [Related]
35. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Girod SC; Pfeiffer P; Ries J; Pape HD Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452 [TBL] [Abstract][Full Text] [Related]
36. p53, Mdm2, and c-Myc overexpression is associated with a poor prognosis in aggressive non-Hodgkin's lymphomas. Pagnano KB; Vassallo J; Lorand-Metze I; Costa FF; Saad ST Am J Hematol; 2001 Jun; 67(2):84-92. PubMed ID: 11343379 [TBL] [Abstract][Full Text] [Related]
37. Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA. Naryzhny SN; Lee H FEBS Lett; 2007 Oct; 581(25):4917-20. PubMed ID: 17900571 [TBL] [Abstract][Full Text] [Related]
38. Proliferation marker MIB-1 correlates well with proliferative activity evaluated by BrdU in breast cancer: an immunohistochemical study including correlation with PCNA, p53, c-erbB-2 and estrogen receptor status. Moriki T; Takahashi T; Kataoka H; Hiroi M; Yamane T; Hara H Pathol Int; 1996 Dec; 46(12):953-61. PubMed ID: 9110347 [TBL] [Abstract][Full Text] [Related]
39. [Regulation of p53 function and promoter selectivity by post-translational modifications]. Tanaka T Seikagaku; 2010 Mar; 82(3):200-9. PubMed ID: 20408452 [No Abstract] [Full Text] [Related]
40. Methylation of the retinoblastoma tumor suppressor by SMYD2. Saddic LA; West LE; Aslanian A; Yates JR; Rubin SM; Gozani O; Sage J J Biol Chem; 2010 Nov; 285(48):37733-40. PubMed ID: 20870719 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]